CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- POS EX Other Post-effective Amendment
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 10-K Report Annual Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Other events
- NT 10-K Other NT 10-K
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change · Other events
- 8-K Event Regulation FD disclosure
- 4/A Open-market buy Director bought 16,667 shares at $6.00 ($100,002)
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 29,167 shares (option exercise)
Page 10 of 13 · 259 filings